Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients

I. M. Abdelfattah, N. Y. Azab, I. H. Diab, G. M. Sharara, S. M. Moaweia (Shebin Elkom, Alexandria, Sadat, Egypt)

Source: Annual Congress 2004 - Clinical pathobiology of airway disorders
Session: Clinical pathobiology of airway disorders
Session type: Thematic Poster Session
Number: 1960
Disease area: Airway diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. M. Abdelfattah, N. Y. Azab, I. H. Diab, G. M. Sharara, S. M. Moaweia (Shebin Elkom, Alexandria, Sadat, Egypt). Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients. Eur Respir J 2004; 24: Suppl. 48, 1960

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of continuous positive airway pressure on plasma B-type natriuretic peptide in patients with respiratory failure and left ventricular dysfunction complicating acute myocardial infarction
Source: Annual Congress 2006 - Acute respiratory failure: diagnostic procedures and clinical management
Year: 2006

Effect of noninvasive ventilation (NIV) on left ventricular (LV) function, B-type natriuretic peptide (BNP) and markers of systemic inflammation in patients with refractory heart failure
Source: Eur Respir J 2006; 28: Suppl. 50, 188s
Year: 2006

N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism
Source: Eur Respir J 2003 Oct 01;22(4):649-653
Year: 2003



Brain natriuretic peptide (BNP) and right ventricular dysfunction predict survival in interstitial lung disease (ILD)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008


Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide
Source: Annual Congress 2007 - New insight into the pathophysiology of asthma
Year: 2007


Atrial natriuretic peptide as a serum marker of right atrial enlargement and function in pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


The application of B-type natriuretic peptide level of the dyspneic patients ; differentiation between cor pulmonale and left ventricular dysfunction
Source: Eur Respir J 2003; 22: Suppl. 45, 583s
Year: 2003

Echocardiography and N-terminal-pro-brain natriuretic peptide in assessment of left ventricular diastolic dysfunction in stable COPD in relation to disease severity
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017

Determination of B-type natriuretic peptide in patients with chronic heart failure and Cheyne-Stokes respiration
Source: Eur Respir J 2004; 24: Suppl. 48, 563s
Year: 2004

Correlation of levels of N-terminal pro-B-type natriuretic peptide with localization of thrombus in acute pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011

Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008


Comparison of brain natriuretic peptide to n-terminal pro brain natriuretic peptide in idiopathic interstitial pneumonia
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009


Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension?
Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment
Year: 2007



B-type natriuretic peptide (BNP) in COPD patients with acute respiratory failure (ARF)
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010

Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure.
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020


Elevated brain natriuretic peptide predicts mortality in interstitial lung disease
Source: Eur Respir J 2010; 36: 819-825
Year: 2010



Brain natriuretic peptide (BNP) levels during acute exacerbations of COPD – a novel biomarker
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008


The utility of brain natriuretic peptide in patients with stable chronic lung diseases
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012


The relationship between pro-BNP(brain natriuretic peptide), c-reactive protein(CRP) and right ventricular dysfunction in pulmonary embolism
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009


NT-proBNP reflects right ventricular structure and function in pulmonary hypertension
Source: Eur Respir J 2006; 28: 1190-1194
Year: 2006